VAS
ABBV icon

Vestmark Advisory Solutions’s AbbVie ABBV Stock Holding History

Vestmark Advisory Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.7M Buy
127,510
+30,233
+31% +$6.71M 0.31% 66
2025
Q4 		$22.2M Buy
97,277
+53,045
+120% +$12.1M 0.3% 63
2025
Q3 		$10.2M Buy
44,232
+1,175
+3% +$239K 0.2% 110
2025
Q2 		$7.99M Buy
43,057
+4,169
+11% +$775K 0.12% 139
2025
Q1 		$8.15M Buy
38,888
+17,788
+84% +$3.46M 0.21% 126
2024
Q4 		$3.75M Buy
21,100
+2,505
+13% +$461K 0.13% 164
2024
Q3 		$3.67M Sell
18,595
-6,116
-25% -$1.14M 0.14% 154
2024
Q2 		$4.24M Buy
24,711
+6,129
+33% +$1.02M 0.18% 129
2024
Q1 		$3.38M Sell
18,582
-864
-4% -$149K 0.15% 172
2023
Q4 		$3.01M Sell
19,446
-1,459
-7% -$213K 0.15% 171
2023
Q3 		$3.12M Sell
20,905
-59,248
-74% -$8.7M 0.23% 103
2023
Q2 		$10.8M Buy
80,153
+1,980
+3% +$290K 0.41% 50
2023
Q1 		$12.5M Sell
78,173
-738
-0.9% -$113K 0.54% 30
2022
Q4 		$12.8M Buy
78,911
+396
+0.5% +$60.7K 0.62% 23
2022
Q3 		$10.5M Buy
78,515
+7,631
+11% +$1.1M 0.59% 24
2022
Q2 		$10.9M Buy
70,884
+11,724
+20% +$1.79M 0.62% 23
2022
Q1 		$9.59M Buy
59,160
+3,413
+6% +$496K 0.54% 29
2021
Q4 		$7.55M Buy
55,747
+2,206
+4% +$261K 0.43% 41
2021
Q3 		$5.78M Buy
53,541
+10,606
+25% +$1.21M 0.39% 45
2021
Q2 		$4.84M Buy
42,935
+1,260
+3% +$142K 0.34% 59
2021
Q1 		$4.51M Buy
41,675
+2,154
+5% +$230K 0.4% 50
2020
Q4 		$4.24M Buy
39,521
+228
+0.6% +$21.9K 0.48% 43
2020
Q3 		$3.44M Buy
39,293
+2,615
+7% +$246K 0.46% 45
2020
Q2 		$3.6M Buy
36,678
+17,974
+96% +$1.58M 0.56% 36
2020
Q1 		$1.43M Buy
18,704
+1,489
+9% +$127K 0.28% 102
2019
Q4 		$1.52M Buy
17,215
+292
+2% +$24.2K 0.31% 115
2019
Q3 		$1.28M Buy
16,923
+4,382
+35% +$300K 0.21% 150
2019
Q2 		$912K Buy
12,541
+248
+2% +$19.5K 0.16% 189
2019
Q1 		$991K Buy
+12,293
New +$1.01M 0.18% 171

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vestmark Advisory Solutions's ABBV Position: Q1 2026 in Review

Vestmark Advisory Solutions increased its AbbVie (ABBV) stake by 31% in Q1 2026, buying an estimated $6.71M and bringing the position to 127,510 shares worth $27.7M. The position accounts for 0.31% of the portfolio, ranked #66.

Vestmark Advisory Solutions first reported a position in ABBV in Q1 2019 and has held it in 29 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Vestmark Advisory Solutions held 127,510 shares of AbbVie worth $27.7M as of Q1 2026.
  • Vestmark Advisory Solutions bought 30,233 AbbVie shares in Q1 2026, an estimated $6.71M.
  • AbbVie made up 0.31% of Vestmark Advisory Solutions's portfolio in Q1 2026, its #66 holding.
  • Vestmark Advisory Solutions first reported a position in AbbVie in Q1 2019 and has held it in 29 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q1 2026, filed 15 May 2026.